Coya Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Coya Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2022 to Q2 2024.
  • Coya Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $6.84K, unchanged year-over-year.
  • Coya Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $27.4K, a 17% decline year-over-year.
  • Coya Therapeutics, Inc. annual Depreciation for 2023 was $27.4K, unchanged from 2022.
  • Coya Therapeutics, Inc. annual Depreciation for 2022 was $27.4K, a 69.6% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $27.4K $6.84K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $27.4K $6.84K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $27.4K $6.84K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $27.4K $6.84K -$5.61K -45.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $33K $6.84K +$2.81K +69.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $30.2K $6.84K +$2.81K +69.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $27.4K $6.84K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $12.5K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $4.03K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $4.03K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.